common: search

Liberty Alliance Announces 1 for 3.5 Reverse Stock Split and Name Change

SHENZHEN, China, July 18 /Xinhua-PRNewswire/ -- Liberty Alliance, Inc. (OTC Bulletin Board: LBTI) announced today that the Company's board of directors and stockholders approved a 1-for-3.5 reverse stock split of the Company's outstanding common stock and a name change to SinoHub, Inc. As a result of the reverse stock split, every 3.5 shares of the Company's common stock will be combined into one share of the Company's common stock. The reverse stock split affects all shares of common stock and stock options of the Company outstanding as of immediately prior to the effective time of the reverse stock split. The number of shares of the Company's common stock currently outstanding is approximately 70 million prior to the reverse stock split and will be reduced to approximately 20 million after the reverse stock split.

China In-Focus: Liberty Alliance Completes Reverse Stock Split, Changes Name

July 18, 2008 (FinancialWire) The board of directors and stockholders of Liberty Alliance Inc. (OTCBB: SIHI) (Current Market Cap. US$63.00 Mil.) have approved a 1-for-3.5 reverse stock split of the company's outstanding common stock and a name change to SinoHub Inc. The company s symbols also changed; SinoHub previously traded with the symbol LBTI. As a result of the reverse stock split, every 3.5 shares of the company's common stock will be combined into one share of the company's common stock. The reverse stock split affects all shares of common stock and stock options of the company outstanding as of immediately prior to the effective time of the reverse stock split. The number of shares of the company's common stock currently outstanding is approximately 70 million prior to the reverse stock split and will be reduced to approximately

Transfer of Escrow Shares of Genius World Investments Limited

RICHMOND (Marketwire) - Further to disclosure requirements of applicable securities laws, Sheng Wang reports that on July 9, 2008, pursuant to a transfer of common escrow shares ("Common Shares") Sheng Wang, President, CEO & CFO acquired beneficial ownership of 800,000 Common Shares of Genius World Investments Limited (the "Company") from Dongdong Huang pursuant to a Share Purchase Agreement dated May 28, 2008, representing 20% of the issued and outstanding Common Shares of the Company. The TSX Venture Exchange Inc. consented to the transfer of escrow shares on June 11, 2008.

Artevo Corporation Completes Amalgamation and Power Play Art Ltd. Closes Minimum Private Placement Amount

CALGARY, ALBERTA--(Marketwire - June 10, 2008) - Artevo Corporation (the "Artevo") (TSX VENTURE:AEV.P) today announced that on May 30, 2008 it amalgamated (the "Amalgamation") with Power Play Art Ltd. ("PPAL") to form a new company to be called "Artevo Corporation" ("Amalco"). This Amalgamation constitutes the Qualifying Transaction of Artevo pursuant to Policy 2.4 of the TSX Venture Exchange Inc. ("TSX Venture"). Pursuant to the Amalgamation: (a) each common share of PPAL was exchanged for one fully-paid and non-assessable common share of Amalco; (b) each existing warrant of PPAL was replaced with/continued into one share purchase warrant of Amalco with identical terms; (c) each common share of Artevo was exchanged for one fully-paid and non-assessable common share of Amalco; (d) each outstanding stock option of PPAL was replaced with/co

Artevo Corporation Completes Amalgamation and Power Play Art Ltd. Closes Minimum Private Placement Amount

CALGARY, ALBERTA--(Marketwire - June 10, 2008) - Artevo Corporation (the "Artevo") (TSX VENTURE:AEV.P) today announced that on May 30, 2008 it amalgamated (the "Amalgamation") with Power Play Art Ltd. ("PPAL") to form a new company to be called "Artevo Corporation" ("Amalco"). This Amalgamation constitutes the Qualifying Transaction of Artevo pursuant to Policy 2.4 of the TSX Venture Exchange Inc. ("TSX Venture"). Pursuant to the Amalgamation: (a) each common share of PPAL was exchanged for one fully-paid and non-assessable common share of Amalco; (b) each existing warrant of PPAL was replaced with/continued into one share purchase warrant of Amalco with identical terms; (c) each common share of Artevo was exchanged for one fully-paid and non-assessable common share of Amalco; (d) each outstanding stock option of PPAL was replaced with/co

Activision Blizzard To Split 2-For-1

July 11, 2008 (FinancialWire) Activision Blizzard, Inc. s (NASDAQ: ATVI) board has approved a two-for-one stock split of its outstanding shares of common stock to be effected in the form of a common stock dividend. The company s stockholders will receive one additional share for each share of common stock held on the record date, which hasn t been set but should coincide with a pending tender offer. Santa Monica, California-based Activision Blizzard is a pure-play online and console game publisher. The company maintains operations in the U.S., Canada, the United Kingdom, France, Germany, Ireland, Italy, Sweden, Spain, Norway, Denmark, the Netherlands, Romania, Australia, Chile, India, Japan, China, the region of Taiwan and South Korea. FinancialWire is a fully independent, proprietary news wire service of Investrend Information (a divisio

Inflazyme Pharmaceuticals announces escrow closing of private placement

Inflazyme Pharmaceuticals Ltd. closes in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Inflazyme Pharmaceuticals Announces Escrow Closing of Private Placement

Inflazyme Pharmaceuticals Ltd. (NEX: IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Inflazyme Pharmaceuticals Announces Escrow Closing of Private Placement

Inflazyme Pharmaceuticals Ltd. (NEX: IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Inflazyme Pharmaceuticals Announces Escrow Closing of Private Placement

VANCOUVER (Marketwire) - Inflazyme Pharmaceuticals Ltd. (NEX:IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Inflazyme Pharmaceuticals Announces Escrow Closing of Private Placement

Vancouver, BC, July 2, 2008--(T-Net)--Inflazyme Pharmaceuticals Ltd. (NEX:IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement for 15,000,000 (3,750,000 post-consolidation) Units. Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Inflazyme Pharmaceuticals Announces Escrow Closing of Private Placement

VANCOUVER, BRITISH COLUMBIA -- 06/30/08 -- Inflazyme Pharmaceuticals Ltd. (NEX: IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Inflazyme Pharmaceuticals Announces Escrow Closing of Private Placement

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 30, 2008) - Inflazyme Pharmaceuticals Ltd. (NEX: IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Inflazyme Pharmaceuticals Announces Escrow Closing of Private Placement

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 30, 2008) - Inflazyme Pharmaceuticals Ltd. (NEX:IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Inflazyme Pharmaceuticals Announces Escrow Closing of Private Placement

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 30, 2008) - Inflazyme Pharmaceuticals Ltd. (NEX:IZP.H) announced today that it has closed in escrow a $300,000 non-brokered unit private placement (the "Offering") for 15,000,000 (3,750,000 post-consolidation) Units (the "Units"). Each Unit consists of one common share and one warrant to purchase a common share (a "Warrant"). The Units were priced at $0.02 ($0.08 post consolidation) per Unit. Each Warrant entitles the holder to acquire one common share at a price of $0.025 ($0.10 post-consolidation) for a period of 12 months. The warrants will not be eligible for listing.

Common virus blamed for 5 infant deaths, CDC says

(AP) -- A common virus traditionally viewed as mild killed at least five U.S. infants last year, government health officials said Thursday.

Common virus may serve as target for vaccine in fight against deadly brain tumors

By targeting a common virus, doctors may be able to extend the lives of patients diagnosed with the most prevalent and deadly type of brain tumor, according to a study led by researchers in Duke’s Preston Robert Tisch Brain Tumor Center.

Common bacteria linked to cot death

There is more reason than ever to believe that two common bacteria are part of the cause of sudden infant death syndrome (SIDS), commonly called cot death.

Common tax base seductive, if it wasn't a 'Trojan horse'

The Treasury has been looking for ways of persuading corporates that things aren’t so bad they need to set up offshore. And now some suggest an unlikely opportunity - a common corporate tax base.

Common aquatic animal's genome can capture foreign DNA

Long viewed as straitlaced spinsters, sexless freshwater invertebrate animals known as bdelloid rotifers may actually be far more promiscuous than anyone had imagined: Scientists at Harvard University have found that the genomes of these common creatures are chock-full of DNA from plants, fungi, bacteria, and animals.

ASHANTI, COMMON, JANET JOIN FOR LOVECHARITY: Campaign features eight artists in total repping respective charities.

Ashanti, Janet Jackson and Common are among a team of eight ambassadors chosen by French jewelry company Cartier for its Lovecharity bracelet campaign.

AirDefense Secures Common Criteria Certification for its Award-Winning Wireless Intrusion Prevention System

AirDefense Secures Common Criteria Certification for its Award-Winning Wireless Intrusion Prevention System

Fishing on Common Grounds: The Consequences of Unregulated Fisheries of North Sea Herring in the Postwar Period

Fishing on Common Grounds: The Consequences of Unregulated Fisheries of North Sea Herring in the Postwar Period

A common aquatic animal's genome can capture foreign DNA

CAMBRIDGE, Mass. -- Long viewed as straitlaced spinsters, sexless freshwater invertebrate animals known as bdelloid rotifers may actually be far more promiscuous than anyone had imagined: Scientists at Harvard University have found that the genomes of these common creatures are chock-full of DNA from plants, fungi, bacteria, and animals.

Coverity reveals common open-source code flaws

A project funded by the US Department of Homeland Security has praised improvements in open source security, while outlining some common errors.

Search took 0.03 seconds.